Venture Capital

A breakthrough stem cell study extends hope for stroke recovery. But a supplement brand is using it to sell 'detox' pills. We separate the facts from fiction.

A routine UK regulatory filing has exposed Arrowstreet Capital's quiet 1.22% stake in the $1.44B American Axle-Dowlais merger, signaling a major quant fund's bet.

A new partnership will test if Acceleware’s radio wave technology can slash energy use in mineral processing, a major step for sustainable resource extraction.

A major CRO presents 10 pivotal studies at the world's top blood disease meeting, revealing a strategy built on real-world data and collaborative innovation.